ZOE-AFFIRM: Relative Validation of a Novel Food Frequency Questionnaire
NCT ID: NCT05612997
Last Updated: 2022-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2022-11-08
2022-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ZOE Health Study: The Intermittent Fasting Study
NCT05558423
Meals and Grazing Study
NCT02548026
Meal Enjoyment and Tolerance: Sex Differences
NCT03408977
Food Frequency Questionnaire for Chinese Pregnant Women
NCT03732196
Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy
NCT05364359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
What is the relative validity of a novel FFQ (Food Frequency Questionnaire) compared to a widely accepted 24h dietary recall tool in a remote setting?
Research Aim:
This study aims to relatively validate the ZFFQ (ZOE Food Frequency Questionnaire; ZOE Ltd) by assessing its agreement with a widely accepted 24h diet recall tool, Intake24 (Newcastle University) in a remote population.
Design:
This study will be conducted in a single-arm design with the intake period under assessment comprising one month.
1. Participants will complete two periods of 3 consecutive days each (one weekend-day and two weekdays, i.e. Sunday-Tuesday or Thursday-Saturday), in which they will complete 6 total rounds of Intake24 (one completion per previous 24 hours). The two periods must be at least 14 days apart; participants will be given multiple options of dates to choose from in November/December that satisfy these requirements.
2. Once the two recall periods are completed, the participant will be asked to fill out the ZFFQ recalling food frequency (without portion sizes) over the preceding month (which encompasses the two recall periods).
Population: In brief, participants are generally healthy UK-based adults who provided consent to participation in this remote study. Please see the eligibility section for full criteria. Participants provided consent before undertaking any study procedures.
Data analysis: Agreement analysis will be used to compare both dietary assessment methods and evaluate the relative validity of the ZOE FFQ.
Data collection:
* Baseline demographic data (age, sex, BMI, ethnicity, smoking, socio-economic status)
* Dietary data (FFQ and 24hr dietary recall)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Relative Validation Arm
Dietary Assessment
Food Frequency Questionnaire and 24h Recalls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary Assessment
Food Frequency Questionnaire and 24h Recalls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are willing and able to comply with all study protocols
* Are willing to complete their dietary recall periods on specified dates
* Have BMI 18 and above
* Are any sex
* Are aged 18 years old and above
* Live in England, Scotland, Wales or Northern Ireland
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zoe Global Limited
OTHER
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah E Berry, PhD
Role: PRINCIPAL_INVESTIGATOR
King's College London and Consultant at ZOE Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ZOE Ltd.
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZOE-AFFIRM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.